Literature DB >> 17336977

Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings.

Pedro Acién1, Irene Velasco, Mercedes Gutiérrez, Monserrat Martínez-Beltrán.   

Abstract

OBJECTIVE: To study the relationship between aromatase expression in endometriotic tissues and clinical and laboratory findings.
DESIGN: Prospective basic and clinical research.
SETTING: University hospital. PATIENT(S): Sixty-two women with endometriosis, and 12 without endometriosis. INTERVENTION(S): Conservative surgery, or hysterectomy and adnexectomy, along with an immunohistochemical study of aromatase in endometriotic and nonendometriotic tissues. MAIN OUTCOME MEASURE(S): Symptoms of the disease, ultrasound and surgical findings, values of tumor markers, steroids and immunoglobulins, and recurrences after surgery. RESULT(S): We observed positive immunohistochemical expression for aromatase in endometriotic tissues from 38 patients (61.3%). Aromatase expression was negative in the rest of the tissues studied and in the 12 cases without endometriosis. Aromatase-positive patients had a higher number of endometriomas, more bilaterality, and more moderate-to-severe chronic pelvic pain. Also, infertility and associated leiomyomas were more frequent in these patients, though without significant differences. There were no differences in recurrence of the disease 1 year later. Estradiol and PRL levels were significantly higher, and IgG values lower, than in aromatase-negative patients. High values of blood sedimentation rate were more frequent in aromatase-negative patients. CONCLUSION(S): Molecular alterations such as the presence of aromatase in endometriotic tissues could be involved in the development or maintenance of endometriosis. Our findings suggest major severity, activity, and chronic pelvic pain in patients with aromatase in endometriotic tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336977     DOI: 10.1016/j.fertnstert.2006.11.188

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

Review 1.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

Review 2.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

3.  The expression and ovarian steroid regulation of endometrial micro-RNAs.

Authors:  Tannaz Toloubeydokhti; Qun Pan; Xiaoping Luo; Orhan Bukulmez; Nasser Chegini
Journal:  Reprod Sci       Date:  2008-12       Impact factor: 3.060

Review 4.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

5.  Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis.

Authors:  Sang Jun Han; Sung Yun Jung; San-Pin Wu; Shannon M Hawkins; Mi Jin Park; Satoru Kyo; Jun Qin; John P Lydon; Sophia Y Tsai; Ming-Jer Tsai; Francesco J DeMayo; Bert W O'Malley
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

6.  Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial.

Authors:  Pedro Acién; Irene Velasco; Maribel Acién
Journal:  BMC Womens Health       Date:  2021-05-20       Impact factor: 2.809

7.  Endometriosis: a disease that remains enigmatic.

Authors:  Pedro Acién; Irene Velasco
Journal:  ISRN Obstet Gynecol       Date:  2013-07-17

Review 8.  The emerging use of aromatase inhibitors for endometriosis treatment.

Authors:  Warren B Nothnick
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

9.  Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model.

Authors:  Yanfen Li; Malavika K Adur; Athilakshmi Kannan; Juanmahel Davila; Yuechao Zhao; Romana A Nowak; Milan K Bagchi; Indrani C Bagchi; Quanxi Li
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

10.  Chronic pelvic pain in endometriosis: an overview.

Authors:  Onofrio Triolo; Antonio Simone Laganà; Emanuele Sturlese
Journal:  J Clin Med Res       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.